Umecrine cognition Headquarters & Office Locations

Umecrine cognition (Private) is headquartered in —, Stockholm County, Sweden. Founded in 2006, the company operates across 1 countries with approximately 12 employees worldwide.

Where is Umecrine cognition's main office?

Umecrine cognition's main headquarters office is located at 2 Fogdevreten, —, Stockholm County 171 65. This serves as the company's primary corporate address and is home to its executive leadership team.

Umecrine cognition regional offices

Beyond its headquarters in —, Umecrine cognition maintains 5 offices across 1 countries. Regional offices span 1 countries.

Umecrine cognition contact information

The main switchboard for Umecrine cognition headquarters can be reached at 46852484482. For investor relations, visit umecrinecognition.com/investor-relations.

What does Umecrine cognition do?

Umecrine Cognition is developing a completely new type of drug for neurological disorders in the brain that can occur as a result of a number of underlying diseases and lead to severely reduced cognition and alertness. The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy. The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the mechanism of action is also relevant in a number of other indication areas. The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy. The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the mechanism of action is also relevant in a number of other indication areas.